Very early thrombolytic therapy in suspected acute myocardial infarction
- 15 February 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (7) , 401-407
- https://doi.org/10.1016/0002-9149(90)90800-g
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- ACHIEVEMENT OF THROMBOLYSIS AT HOME IN CASES OF ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA: The Committee on Enzymes of The Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE)Scandinavian Journal of Clinical and Laboratory Investigation, 1979
- Recommended Methods for the Determination of Four Enzymes in BloodScandinavian Journal of Clinical and Laboratory Investigation, 1974